<?xml version="1.0" encoding="UTF-8"?>
<ref id="B260-vaccines-08-00036">
 <label>260.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wunderlich</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Chou</surname>
    <given-names>F.S.</given-names>
   </name>
   <name>
    <surname>Link</surname>
    <given-names>K.A.</given-names>
   </name>
   <name>
    <surname>Mizukawa</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Perry</surname>
    <given-names>R.L.</given-names>
   </name>
   <name>
    <surname>Carroll</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Mulloy</surname>
    <given-names>J.C.</given-names>
   </name>
  </person-group>
  <article-title>AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3</article-title>
  <source>Leukemia</source>
  <year>2010</year>
  <volume>24</volume>
  <fpage>1785</fpage>
  <lpage>1788</lpage>
  <pub-id pub-id-type="doi">10.1038/leu.2010.158</pub-id>
  <pub-id pub-id-type="pmid">20686503</pub-id>
 </element-citation>
</ref>
